| Artelac 3.2 mg/ml Eye Drops, Solution PA23259/004/001 |
Hypromellose |
Bausch + Lomb Ireland Limited |
Marketed |
| Artelac Preservative Free Single Dose Unit PA23259/004/002 |
Hypromellose |
Bausch + Lomb Ireland Limited |
Marketed |
| Geltears 0.2 % w/w carbomer eye gel PA23259/006/001 |
Carbomer |
Bausch + Lomb Ireland Limited |
Marketed |
| Liposic 2 mg/g eye gel PA23259/009/001 |
Carbomer |
Bausch + Lomb Ireland Limited |
Marketed |
| Lumobry 0.25 mg/mL eye drops, solution PA23259/024/001 |
Brimonidine tartrate |
Bausch + Lomb Ireland Limited |
Not marketed |
| Minims Artificial Tears 0.35% w/w + 0.44% w/w Eye Drops, Solution PA23259/013/001 |
Sodium chloride, Hydroxyethylcellulose |
Bausch + Lomb Ireland Limited |
Not marketed |
| Minims Atropine Sulphate 1% Eye Drops, solution PA23259/007/001 |
Atropine sulfate |
Bausch + Lomb Ireland Limited |
Marketed |
| Minims Chloramphenicol 0.5% Eye Drops, Solution PA23259/010/001 |
Chloramphenicol |
Bausch + Lomb Ireland Limited |
Marketed |
| Minims Cyclopentolate Hydrochloride 1% w/v Eye Drops, solution PA23259/011/001 |
Cyclopentolate hydrochloride |
Bausch + Lomb Ireland Limited |
Not marketed |
| Minims Fluorescein Sodium 2%, w/v Eye Drops, Solution PA23259/012/002 |
Fluorescein sodium |
Bausch + Lomb Ireland Limited |
Marketed |
| Minims Lidocaine Hydrochloride 4% w/v & Fluorescein Sodium 0.25% w/v Eye Drops, solution PA23259/014/001 |
Fluorescein sodium, Lidocaine hydrochloride |
Bausch + Lomb Ireland Limited |
Marketed |
| Minims Oxybuprocaine Hydrochloride 0.4% w/v Eye Drops Solution PA23259/015/001 |
Oxybuprocaine hydrochloride |
Bausch + Lomb Ireland Limited |
Marketed |
| Minims Phenylephrine Hydrochloride 2.5% w/v eye drops, solution PA23259/016/001 |
Phenylephrine hydrochloride |
Bausch + Lomb Ireland Limited |
Marketed |
| Minims Pilocarpine Nitrate 2% w/v, Eye Drops, Solution PA23259/017/001 |
Pilocarpine nitrate |
Bausch + Lomb Ireland Limited |
Marketed |
| Minims Povidone Iodine 5% w/v Eye Drops, Solution PA23259/018/001 |
Iodinated povidone |
Bausch + Lomb Ireland Limited |
Marketed |
| Minims Prednisolone Sodium Phosphate 0.5% w/v Eye Drops, Solution PA23259/019/001 |
Prednisolone sodium phosphate |
Bausch + Lomb Ireland Limited |
Marketed |
| Minims Proxymetacaine hydrochloride 0.5% w/v, Eye Drops, Solution PA23259/020/001 |
PROXYMETACAINE HYDROCHLORIDE |
Bausch + Lomb Ireland Limited |
Marketed |
| Minims Saline 0.9% w/v Eye Drops, Solution PA23259/021/001 |
Sodium chloride |
Bausch + Lomb Ireland Limited |
Not marketed |
| Minims Tetracaine Hydrochloride 0.5% w/v Eye Drops, Solution PA23259/022/001 |
Tetracaine hydrochloride |
Bausch + Lomb Ireland Limited |
Not marketed |
| Minims Tetracaine Hydrochloride 1% w/v Eye Drops, Solution PA23259/022/002 |
Tetracaine hydrochloride |
Bausch + Lomb Ireland Limited |
Marketed |
| Minims Tropicamide 0.5 % w/v Eye drops, solution PA23259/023/001 |
Tropicamide |
Bausch + Lomb Ireland Limited |
Marketed |
| Minims Tropicamide 1% w/v Eye drops, solution PA23259/023/002 |
Tropicamide |
Bausch + Lomb Ireland Limited |
Marketed |
| Vidisic 0.2 % w/w eye gel PA23259/008/001 |
Carbomer |
Bausch + Lomb Ireland Limited |
Marketed |
| Vidisic Preservative Free Single Dose Unit PA23259/008/002 |
Carbomer |
Bausch + Lomb Ireland Limited |
Marketed |
| Vividrin Preservative Free SDU 2% w/v Eye Drops solution PA23259/005/002 |
Sodium cromoglycate |
Bausch + Lomb Ireland Limited |
Marketed |